Taking an immunosuppressant does not automatically rule out platelet-rich plasma, but it changes the assessment. The relevant questions are why you take the medicine, whether treatment is stable, whether there is any infection and whether PRP is a reasonable option for the actual joint or tendon problem. Do not stop essential treatment to make yourself eligible for an elective injection.
This article concerns musculoskeletal PRP. Guidance about injections for joints and tendons should not be presented as proof of safety or benefit for hair, facial or other cosmetic PRP. Different indications need their own evidence and clinical assessment. [1]
What does the latest specific consensus say?
A 2025 GRIIP formal consensus states that PRP may be performed in people on prolonged, stable immunosuppressive treatment, with particular attention to concomitant infection. This is permission to consider treatment after assessment, not a guarantee that an injection is safe or effective for every person on these medicines. [1]
The recommendation was graded C. Much of the wider consensus rests on expert opinion because direct evidence is limited. It is important to distinguish a cautious consensus statement from a large trial demonstrating benefit in a particular transplant, autoimmune or inflammatory-disease population. [1]
Ask The Wellness about a PRP suitability assessment. Give the team your diagnosis, medicine list and the joint or tendon problem before arranging treatment. An assessment may lead to a different treatment or a decision to defer.
Why is the reason for the medicine important?
The same medicine can be used for different conditions. The underlying illness, previous complications and stability of treatment may matter as much as the medicine name. A transplant recipient and someone with a stable inflammatory condition do not necessarily have the same risks or monitoring needs.
The PRP clinician needs an accurate history, including recent dose changes, infections, hospital treatment and relevant specialist advice. An active flare, a new diagnosis or a recent major treatment change may need clarification before an elective injection can be planned. There is no sound basis for a universal online clearance rule.
Why is infection the central concern?
PRP is prepared from your own blood, but that does not remove infection risk. Blood collection, preparation and injection still require careful technique, and infection elsewhere may alter the suitability of an elective procedure. The 2025 consensus specifically draws attention to infection in people receiving stable immunosuppressants. [1]
Tell the clinician about fever, new cough or other illness, skin wounds, recent antibiotics and problems around the proposed injection site. Do not conceal an infection because an appointment is difficult to rearrange. A delay can be the safest outcome of a careful assessment.
If you are acutely unwell, follow your specialist's infection advice or seek urgent clinical assessment. A PRP consultation is not a substitute for evaluating a possible serious infection.
Should you pause an immunosuppressant?
Do not make that change yourself. Stopping or altering treatment can risk a flare or other harm, and the decision belongs with the prescribing specialist. There is no single stopping interval that can be applied safely to all immunosuppressants or all patients.
If a clinic suggests a pause, ask why it is necessary, what evidence supports it and whether the prescriber has agreed. The plan should specify who is responsible for any change and what to do if the underlying condition worsens. An elective injection should not destabilise essential care.
Do you need blood tests before PRP?
Sometimes, but the choice depends on the clinical situation. The consensus recommends investigating a significant blood-count abnormality before PRP. Existing monitoring results may be useful, particularly if the underlying condition or medicine affects blood counts. [1]
A normal blood count does not prove there is no infection or guarantee a good response. Conversely, a flagged value does not always mean treatment is impossible. Ask which result would change the decision and who will review it, rather than paying for a broad panel without an identified purpose.
Does PRP work better because it uses your own blood?
No such conclusion follows. Autologous means derived from your own body; it does not mean risk-free or predict the size of benefit. Evidence for PRP varies by diagnosis, study design, preparation and comparison treatment. A suitability statement about immunosuppressants is not an efficacy statement. [1]
The 2025 consensus recommends an individual benefit-risk assessment that considers the lesion, medical history, treatments and alternatives. It also calls for clear personalised information and recorded consent. These are useful standards to ask any provider to meet. [1]
What alternatives should be discussed?
The right alternatives depend on the diagnosis. They can include rehabilitation, changes in loading, other medical treatments or specialist assessment. An injection should not be used to bypass uncertainty about whether pain comes from a tendon, joint, inflammatory disease or another cause.
Ask what PRP is expected to achieve, how improvement will be measured and what happens if there is no meaningful benefit. If the provider cannot explain why PRP fits your condition, a reassuring answer about your medicine is not enough to justify treatment.
How should your specialists be involved?
Bring a concise summary from the team managing the underlying illness when available. It should identify the diagnosis, current treatment, relevant recent results and any procedure-related concerns. The injection clinician may need to contact that team with your consent before a decision can be made.
This is particularly useful when care is split between different hospitals or countries. A short, specific clinical question is more useful than a general request to declare that all future PRP is safe. Clearance for one procedure does not become a permanent guarantee.
What to bring to an assessment
Bring your medicine names and doses, recent monitoring results, specialist letters and imaging of the affected area. Include recent infections, treatment changes and previous injection reactions. Ask whether the planned procedure should be delayed and what would need to change before reconsideration.
Contact The Wellness to discuss suitability before booking a treatment course. The aim is to decide whether PRP has a reasonable place in your care, not to fit every medical history into an injection package.
Source and limits
The consensus concerns musculoskeletal PRP and has important evidence limitations. It does not establish safety for every immunosuppressant or prove treatment benefit. General information only. Reviewed 31 October 2026.